TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY

透皮离子电渗疗法和多肽输送

基本信息

  • 批准号:
    2181850
  • 负责人:
  • 金额:
    $ 18.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-12-01 至 1998-11-30
  • 项目状态:
    已结题

项目摘要

This proposal seeks to implement a novel, systematic approach (developed during the past project period) to study the iontophoretic transport properties of human skin. The long term objective is to gain a basic and comprehensive understanding with the information to become a significant part of the fundamental data base to materially assist drug delivery scientists in the rational design of practical iontophoretic systems for trans- dermal drug delivery, especially for polypeptide drug delivery. The approach combines a rigorous theoretical framework (the modified Nernst- Planck theory) with judiciously designed experiments to factor out the various contributions to human skin iontophoresis. The effects of physical chemical factors such as the molecular size/configuration and charge of the permeant, the ionic strength and pH of the electrolyte solution, and the mode of iontophoresis (continuous D.C. versus pulsed D.C.) upon the iontophoretic flux of the permeant will be systematically investigated. The general question will be addressed: is polypeptide transport (both passive and iontophoretic) in accord with the modified Nernst-Planck theory? The phenomenon of field induced pore induction (electroporation) with the human epidermal membrane (HEM) will receive particular attention, and answers to the following questions will be sought. How do HEM permeability and pore size vary with amplitude and duration of the applied voltage? How do the relative contributions of the direct field effect and convective (electroosmotic) solvent flow vary with electroporation? Under what voltage regimens may alternating pulses or sinusoidal A.C. yield electroporation effects? The actions of chemical permeation enhancers operating via several different mechanisms will be systematically investigated, and the importance of the different mechanisms quantified. These enhancer situations will include (a) agents interacting directly with HEM to increase the effective pore size and/or the porosity/ tortuosity ratio, (b) enhancers influencing the rate, extent, and/or the threshold voltage of electroporation, and (c) agents influencing the direction and magnitude of electroosmosis. Finally, select studies will be conducted to assess the clinical relevance of important outcomes from the above in vitro HEM studies in an in vivo animal model (developed during the past project period).
本建议寻求实施一种新颖的、系统化的方法

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William I Higuchi其他文献

William I Higuchi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William I Higuchi', 18)}}的其他基金

Novel Method for the Ocular Iontophoretic Delivery of Avastin and Lucentis
眼部电离子导入阿瓦斯汀和雷珠单抗的新方法
  • 批准号:
    7927575
  • 财政年份:
    2010
  • 资助金额:
    $ 18.43万
  • 项目类别:
Non-Invasive Treatment for Uveitis
葡萄膜炎的非侵入性治疗
  • 批准号:
    9060548
  • 财政年份:
    2004
  • 资助金额:
    $ 18.43万
  • 项目类别:
Non-Invasive Treatment for Uveitis
葡萄膜炎的非侵入性治疗
  • 批准号:
    8455734
  • 财政年份:
    2004
  • 资助金额:
    $ 18.43万
  • 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDES
透皮离子电渗疗法和多肽
  • 批准号:
    3302156
  • 财政年份:
    1989
  • 资助金额:
    $ 18.43万
  • 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDES
透皮离子电渗疗法和多肽
  • 批准号:
    2181848
  • 财政年份:
    1989
  • 资助金额:
    $ 18.43万
  • 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDES
透皮离子电渗疗法和多肽
  • 批准号:
    3302158
  • 财政年份:
    1989
  • 资助金额:
    $ 18.43万
  • 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY
透皮离子电渗疗法和多肽输送
  • 批准号:
    2608906
  • 财政年份:
    1989
  • 资助金额:
    $ 18.43万
  • 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY
透皮离子电渗疗法和多肽输送
  • 批准号:
    2022341
  • 财政年份:
    1989
  • 资助金额:
    $ 18.43万
  • 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY
透皮离子电渗疗法和多肽输送
  • 批准号:
    2181851
  • 财政年份:
    1989
  • 资助金额:
    $ 18.43万
  • 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDES
透皮离子电渗疗法和多肽
  • 批准号:
    3302159
  • 财政年份:
    1989
  • 资助金额:
    $ 18.43万
  • 项目类别:

相似海外基金

ERI: Revealing the Reconfiguration Dynamics of Lipid Bilayer and Its Hydration Structures with Nanoscale Resolution during Electroporation
ERI:以纳米级分辨率揭示电穿孔过程中脂质双层的重构动力学及其水合结构
  • 批准号:
    2302013
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Standard Grant
Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications
高频不可逆电穿孔 (H-FIRE) 的优化,用于胰腺癌应用中的肿瘤消融和免疫系统激活
  • 批准号:
    10659581
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer
不可逆电穿孔 (IRE) 联合 CD40 激动作为胰腺癌原位疫苗治疗
  • 批准号:
    10718057
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
Self-powered disinfection of Viruses and Bacteria in water using Oxidation-assisted electroporation and Tribo-Electric Nanogenerators (VIBO-TENG)
使用氧化辅助电穿孔和摩擦纳米发电机 (VIBO-TENG) 对水中的病毒和细菌进行自供电消毒
  • 批准号:
    EP/X022730/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Fellowship
Identification of impedance measurement devices, heating hardware, and operating parameters to augment instrumentation for a commercial in vivo electroporation system
识别阻抗测量装置、加热硬件和操作参数,以增强商业体内电穿孔系统的仪器
  • 批准号:
    10484502
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
  • 批准号:
    10363932
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
Adaptable and scalable electroporation for cellular therapy
用于细胞治疗的适应性和可扩展的电穿孔
  • 批准号:
    10545845
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
  • 批准号:
    10559607
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable Tumors
学术与工业合作开发用于不可手术肿瘤的算法不可逆电穿孔的临床工具
  • 批准号:
    10504276
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
ex vivo electroporation培養法による歯の運命決定因子の探索
利用离体电穿孔培养法寻找决定牙齿命运的因素
  • 批准号:
    22K17233
  • 财政年份:
    2022
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了